|
Name |
pestalotione A
|
Molecular Formula | C17H12O8 | |
IUPAC Name* |
1-hydroxy-6-methoxy-8-methoxycarbonyl-9-oxoxanthene-3-carboxylicacid
|
|
SMILES |
COC(=O)c1cc(OC)cc2oc3cc(C(=O)O)cc(O)c3c(=O)c12
|
|
InChI |
InChI=1S/C17H12O8/c1-23-8-5-9(17(22)24-2)13-12(6-8)25-11-4-7(16(20)21)3-10(18)14(11)15(13)19/h3-6,18H,1-2H3,(H,20,21)
|
|
InChIKey |
SFHNQBUWOYIXAB-UHFFFAOYSA-N
|
|
Synonyms |
NA
|
|
CAS | NA | |
PubChem CID | NA | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 344.28 | ALogp: | 2.1 |
HBD: | 2 | HBA: | 7 |
Rotatable Bonds: | 3 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 123.3 | Aromatic Rings: | 3 |
Heavy Atoms: | 25 | QED Weighted: | 0.549 |
Caco-2 Permeability: | -4.989 | MDCK Permeability: | 0.00001890 |
Pgp-inhibitor: | 0.006 | Pgp-substrate: | 0.002 |
Human Intestinal Absorption (HIA): | 0.225 | 20% Bioavailability (F20%): | 0.022 |
30% Bioavailability (F30%): | 0.975 |
Blood-Brain-Barrier Penetration (BBB): | 0.116 | Plasma Protein Binding (PPB): | 78.94% |
Volume Distribution (VD): | 0.952 | Fu: | 16.79% |
CYP1A2-inhibitor: | 0.327 | CYP1A2-substrate: | 0.942 |
CYP2C19-inhibitor: | 0.044 | CYP2C19-substrate: | 0.05 |
CYP2C9-inhibitor: | 0.512 | CYP2C9-substrate: | 0.174 |
CYP2D6-inhibitor: | 0.485 | CYP2D6-substrate: | 0.125 |
CYP3A4-inhibitor: | 0.069 | CYP3A4-substrate: | 0.034 |
Clearance (CL): | 1.358 | Half-life (T1/2): | 0.91 |
hERG Blockers: | 0.012 | Human Hepatotoxicity (H-HT): | 0.091 |
Drug-inuced Liver Injury (DILI): | 0.985 | AMES Toxicity: | 0.059 |
Rat Oral Acute Toxicity: | 0.005 | Maximum Recommended Daily Dose: | 0.138 |
Skin Sensitization: | 0.185 | Carcinogencity: | 0.012 |
Eye Corrosion: | 0.005 | Eye Irritation: | 0.817 |
Respiratory Toxicity: | 0.263 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC003136 | 0.770 | D06GCK | 0.330 | ||||
ENC002462 | 0.641 | D0K8KX | 0.306 | ||||
ENC002690 | 0.598 | D0N1FS | 0.306 | ||||
ENC001750 | 0.577 | D04AIT | 0.299 | ||||
ENC002523 | 0.577 | D0G5UB | 0.293 | ||||
ENC003543 | 0.573 | D06NSS | 0.283 | ||||
ENC002106 | 0.537 | D06FVX | 0.282 | ||||
ENC002197 | 0.529 | D0G7IY | 0.273 | ||||
ENC003814 | 0.529 | D0R1RS | 0.257 | ||||
ENC006013 | 0.518 | D0QD1G | 0.256 |